- The World Economic Forum and Frontiers jointly released the 2026 Top 10 Emerging Technologies Report, highlighting that scientific breakthroughs are rapidly becoming reality. Human decisions will shape their future form, with a focus on evaluating regulation and potential risks.
- The report includes ten technologies across six major fields: energy, materials, food, medicine, artificial intelligence, and cybersecurity, showcasing a trend towards high personalization, decentralization, and efficiency.
- The report warns that the implementation of technology comes with core challenges of trust and fairness. Without policy intervention, benefits may concentrate among advantaged groups, making policy a prerequisite for building trust.
Energy and Materials Revolution Reshapes Distributed Grid Ecosystem
The commercialization breakthrough of the Internet of Everything and next-generation battery technology is driving a shift from centralized power generation to a coordinated network of distributed assets. The operation of Argentina's industrial lithium extraction plant and California's geothermal power project receiving federal loan support highlight the reevaluation of commodity supply chain value through direct lithium extraction technology. Daikin Industries' commercial deployment of PFAS destruction technology reflects the flow of funds towards green premium assets under tightened environmental regulations, with related energy and materials sectors poised for a valuation reassessment.
Precision Biomedicine Reaches a Personalized Clinical Turning Point
Precision medicine is evolving towards personalization and targeting. Eli Lilly and Evox Therapeutics signed a $1.5 billion agreement to jointly develop an exosome drug delivery system, marking a resurgence in risk appetite for innovative drugs in the neurological disease sector. Meanwhile, Nestlé is introducing precision fermentation into its functional nutrition product line. Although high costs pose a risk of privilege in precision medicine, the overall commercialization expectations of the industry chain are significantly strengthening, guiding accelerated capital inflow into the pharmaceutical sector.
AI in the Physical World and Frontier Cryptography Build Cognitive Infrastructure
Artificial intelligence is experiencing a paradigm shift towards world models. NVIDIA's release of the Cosmos platform enables robots to perform reasoning in real-world scenarios, injecting growth momentum into the technology and semiconductor sectors. In the field of cybersecurity, with the U.S. National Security Agency requiring national security systems to deploy post-quantum encryption by 2027, lattice cryptography is established as a core standard. Policy expectations are triggering an investment wave towards quantum-safe public systems, reshaping valuations in the cybersecurity sector.
Quantum Simulation Accelerates Computing Power, Disrupting Traditional Pharmaceutical R&D Paradigms
Quantum simulation can model at the atomic scale, overcoming the limitations of traditional computers that lead to a 90% clinical failure rate for new drugs. IBM and Moderna have completed large-scale quantum protein folding simulations, with real-world quantum advantage cases expected by 2026. This turning point is guiding the marginal shift of R&D funding from pharmaceutical giants and tech companies, reducing sunk costs in new drug development and accelerating the transformation of the biopharmaceutical industry chain towards a high-efficiency paradigm.